Bashar Hamad
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Atrial Fibrillation Management and Outcomes 3
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Blood Coagulation and Thrombosis Mechanisms 2
- Co-authors
- Peter N. Kirkpatrick (3 shared papers)Basharut A. Syed (2 shared papers)Rami A. Al‐Horani (2 shared papers)Kurt Huber (1 shared paper)Uma Yasothan (1 shared paper)Jalal K. Ghali (1 shared paper)Peter J. Kirkpatrick (1 shared paper)Dobromir Dobrev (1 shared paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Bashar Hamad
15 papers receiving 506 citations
Peers
Comparison fields: 5 of 78
- Applied Microbiology and Biotechnology 15
- Molecular Medicine 37
- Pollution 46
- Pharmacology 42
- Filtration and Separation 5
Countries citing papers authored by Bashar Hamad
This map shows the geographic impact of Bashar Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bashar Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bashar Hamad more than expected).
Fields of papers citing papers by Bashar Hamad
This network shows the impact of papers produced by Bashar Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bashar Hamad. The network helps show where Bashar Hamad may publish in the future.
Co-authors
The 12 scholars most cited alongside Bashar Hamad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 239 | |
| 2 | 2015 | 47 | |
| 3 | 2014 | 29 | |
| 4 | 2009 | 28 | |
| 5 | 2011 | 28 | |
| 6 | 2021 | 26 | |
| 7 | 2019 | 24 | |
| 8 | 2016 | 19 | |
| 9 | 2010 | 17 | |
| 10 | 2017 | 17 | |
| 11 | 2018 | 15 | |
| 12 | 2009 | 13 | |
| 13 | 2024 | 9 | |
| 14 | 2014 | 5 | |
| 15 | 2015 | 4 |
About Bashar Hamad
Bashar Hamad is a scholar working on Cardiology and Cardiovascular Medicine, Hematology, Applied Microbiology and Biotechnology, Molecular Medicine and Dermatology, having authored 15 papers that have together received 520 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (3 papers), Pharmaceutical Economics and Policy (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Dermatology and Skin Diseases (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Psoriasis: Treatment and Pathogenesis (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (15 citations), Molecular Medicine (37 citations), Pollution (46 citations), Pharmacology (42 citations) and Filtration and Separation (5 citations). Bashar Hamad has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Peter N. Kirkpatrick, Basharut A. Syed, Rami A. Al‐Horani, Kurt Huber, Uma Yasothan, Jalal K. Ghali, Peter J. Kirkpatrick, Dobromir Dobrev, Ian M. Sander and Arvind Kumar. Their work appears in journals such as Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.